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ABSTRACT
OBJECTIVE: To characterize the process of selection of medicines for primary health care in 
the Brazilian regions.
METHODS: This article is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do 
Uso Racional de Medicamentos – Serviços, 2015 (PNAUM – National Survey on Access, Use and 
Promotion of Rational Use of Medicines – Services, 2015), a cross-sectional study that consisted 
of an information gathering in a sample of cities in the five regions of Brazil. The data used 
were collected by interviews with those responsible for pharmaceutical services (PS) (n = 506), 
professionals responsible for the dispensing of medicines (n = 1,139), and physicians (n = 1,558). 
To evaluate the difference between ratios, we adopted the Chi-square test for complex samples. 
The differences between the averages were analyzed in generalized linear models with F-test with 
Bonferroni correction for multiple comparisons. The analyses considered significant had p≤0.05.
RESULTS: The professionals responsible for pharmaceutical services reported non-existence 
of a formally constituted Pharmacy and Therapeutics Committee (PTC) (12.5%). They claimed 
to have an updated (80.4%) list of Essential Medicines (85.3%) and being active participants of 
this process (88.2%). However, in the perception of respondents, the list only partially (70.1%) 
meets the health demands. Of the interviewed professionals responsible for the dispensing of 
medicines, only 16.6% were pharmacists; even so, 47.8% reported to know the procedures to 
change the list. From the perspective of most of these professionals (70.9%), the list meets the 
health demands of the city. Among physicians, only 27.2% reported to know the procedures to 
change the list, but 76.5% would have some claim to change it. Most of them reported to base 
their claims in clinical experiences (80.0%). For 13.0% of them, the list meets the health demands. 
CONCLUSIONS: As this is the first national survey of characterization of the process of selection 
of medicines within primary health care, it brings unpublished data for the assessment of policies 
related to medicines in Brazil. 
DESCRIPTORS: Drugs, Essential, classification. Pharmacy and Therapeutics Committee. 
Pharmaceutical Services. National Policy of Pharmaceutical Assistance. Primary Health Care. 
Health Services Research. Unified Health System.
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INTRODUCTION
Selection of medicines is a guiding axis for actions of planning and organization of 
pharmaceutical services (PS)6. If well conducted, it provides economic gains to the Brazilian 
Unified Health System (SUS), as well as to the access to effective, safe, and cost-effective 
medicines for the patients of the System6. However, in Brazil, weaknesses and barriers can 
be observed in the selection process, which are critical for the implementation of access 
and rational use of medicines by the population3. 
For the selection to occur adequately, it must meet certain requirements, such as the 
establishment of a Pharmacy and Therapeutics Committee (PTC), which is responsible for 
the technical, political, and administrative conduction of the process4. The main product of 
this process is a list of essential medicines (LME), from which should derive the therapeutic 
form and clinical guidelines. The LME, based on an epidemiological perspective, must contain 
essential medicines for public health, having their effectiveness, safety, and quality assured 
and being prescribed and used rationally11. 
The selection has the potential to produce results that guide both clinical conducts and 
management activities related to medicines provided by SUS11. To this end, the selection 
process must involve the articulation of different actors, especially health managers and 
professionals, both nationally and locally3. 
According to the Política Nacional de Medicamentos (PNM – National Drug Policy)7, the 
existence of a Relação Nacional de Medicamentos Essenciais (Rename – National List of 
Essential Medicines) does not exempt the responsibility of states, cities, and Federal District to 
manage their own lists. Therefore, the selection of medicines at local level requires managers 
to define priorities and effectively allocate human and financial resources to strengthen and 
qualify the decentralization of the management4. 
Brazil created its first LME over 50 years ago, and the Brazilian Ministry of Health invested 
on the development and publication of sequential Renames between 2002 and 2014, as well 
as on the reorientation of the qualification of pharmaceutical services9. Despite this, there 
are still many challenges regarding the selection of medicines in the Country3. 
Marques and Zucchi5, for example, mention that few publications disclose the existence 
of PTC in outpatient and hospital services of SUS. In another national survey, entitled Fala 
Essencial, in which PS managers discuss their perception of the medicine selection process, of 
the 20 locations visited, only two states and five cities had LME3, in contradiction to the PNM7. 
Thus, studies dealing with the selection of medicines in Brazil are scarce. The existing ones 
identified the lack of adoption of LME in the cities and in the Federal District, the inexpressive 
standardization of PTC, and the low rates of use of therapeutic forms and clinical protocols 
in primary health care3,5,10,11. 
The Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos – 
Serviços, 2015  (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines 
– Services, 2015) aimed to characterize the organization of pharmaceutical services in the primary 
health care of  SUS, to promote the access and rational use of medicines, as well as to identify and 
discuss the factors that affect the consolidation of pharmaceutical services in the cities.
This article is part of PNAUM – Services and aimed to characterize the selection process in 
the primary health care of the Brazilian regions. 
METHODS
PNAUM – Services is a cross-sectional, exploratory, and evaluative study, consisting of an 
information gathering in a sample of cities and Federal District, representative to the five 
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Brazilian regions. Several study populations were considered in the sampling, with samples 
stratified by the regions, which constituted the study domains. The PNAUM – Services 
methodology, as well as the sampling process, are described in detail by Álvares et al. (2017)1.
The data used in this study were collected from the databases of those responsible for 
pharmaceutical services, professionals responsible for the dispensing of medicines in 
Unidades Básicas de Saúde (UBS – Basic Health Units), and physicians from the UBS. The data 
were collected by interviews, adopting semi-structured scripts, via telephone or in person.
For determining the profile of respondents, we collected information on sex, age, education level, 
time in the position, and time of training. The characterization of the selection of medicines 
process was carried out by the analysis of the variables related to PTC, of the existence of 
standard operating procedures, List of Municipal Medicines (LMM), therapeutic form and/or 
clinical protocols, consensus or guidelines, and provision of non-standard medicines. 
For this characterization, semi-structured questionnaires were adopted, which sought to 
describe the perceptions of respondents, i.e., the perception of coordinators of pharmaceutical 
services, of professionals responsible for the dispensation of medicines, and of physicians. The 
questions asked to these three actors were not coincident, but complementary, to show with 
greater comprehensiveness the selection of medicines scenario in the cities and Federal District.
Data analyses were performed using the SPSS 20.0 program, adopting the analysis module 
for complex samples. The variables were presented for Brazil and for each geographic region. 
The numerical variables were presented by the averages and by the 95% confidence interval 
(95%CI) of the averages. Categorical variables were presented by proportions and their 95%CI.
To evaluate the difference between ratios, we adopted the Chi-square test for complex 
samples. The assessment of the differences between averages was performed by generalized 
linear models, and the F-test with Bonferroni correction was adopted for multiple 
comparisons. The analyses considered significant had p ≤ 0.05.
PNAUM was approved by the National Research Ethics Committee, under Opinion no. 
398,131, September 16, 2013, with clarification of the research’s objectives to the respondents 
and signing of the informed consent form. 
RESULTS
Among respondents, 1,558 were physicians and 1,139, professionals responsible for the dispensing 
of medicines in the pharmacies of the health units of the cities that composed the sample. We also 
conducted interviews by telephone with 506 coordinators of pharmaceutical services of the cities. 
Table 1 presents the results of the profile of the professionals interviewed. Among those 
responsible for pharmaceutical services, the female sex prevailed (62%, 95%CI 56.9–66.9), 
with an average age of  34.8 years (95%CI 34.0–35.6), and higher education degree level (97.7%; 
95%CI 95.8–98.7), among which 23.4% had attended a graduate course (95%CI 19.3–28.0). 
Almost all respondents (90.7%, 95%CI 87.3–93.4) declared to be pharmacists and with an 
average time in the position of over three years. 
In the case of professionals responsible for the dispensing of medicines in the UBS, the female 
sex also prevailed (77.4%, 95%CI 71.2–82.6) and the average age was 37.5 years (95%CI 36.5–38.6). 
Concerning education level, 50.3% (95%CI 43.0–57.7) reported to have up to high school, and, 
of those who had higher education degree or graduate courses, only 16.6% (95%CI 12.4–21.7) 
were pharmacists. The average time in the position at the UBS was around four and a half years.
Regarding physicians, 55.8% were male (95%CI 52.2–59.2) and the average age was 41.3 years 
(95%CI 40.5–42.1). The time since graduation was asked only to physicians, whose average 
was 13.5 years (95%CI 12.8–14.3). The average working time in the position at the UBS where 
the interview was carried out was 39.3 months (95%CI 35.8–42.8), a little lower than that of 
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the other interviewed professionals. 90.5% (95%CI 88.0–92.5) of physicians reported to have 
at least one residency course. 
Few coordinators of pharmaceutical services reported the existence of a formally constituted 
PTC (12.5%; 95%CI 9.5–16.3). This proportion was lower in the Northeast and North regions 
(9.5% and 10.7%, respectively) and greater in the South (15.6%), although the difference is 
not statistically significant (Table 2). 
Most coordinators (85.3%; 95%CI 81.4–88.5) stated that the city had an LME, of which 80.4% 
(95%CI 75.6–84.5) were considered to be periodically updated. Furthermore, approximately 
half of them declared to adopt standard operating procedures (SOP) to perform the selection 
of medicines in the cities (Table 2).
Still in Table 2, most coordinators (88.2%; 95%CI 84.0–91.4) claimed to have participated 
in the development of a LME in the city or Federal District. The request for changing the 
LME (inclusion and exclusion of medicines or intended use) seems to not be very frequent 
Table 1. Profile of participants of the selection process, interviewed by region in Brazil. National Survey on Access, Use and Promotion of 
Rational Use of Medicines – Services, 2015.
Profile of respondents
North Northeast Midwest Southeast South Brazil
p
% (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI)
Professionals responsible for pharmaceutical services
Sex (n = 506) 
Female 64.4 (54.0–73.6) 49.9 (39.0–60.8) 67.3 (57.3–75.9) 63.2 (53.1–72.3) 73.2 (63.7–81.0) 62.0 (56.9–66.9) 0.008
Age (n = 493) 
Average in years 34.2 (32.3–36.0) 37.1 (34.8–39.4) 31.8 (30.2–33.3) 35.5 (33.8–37.3) 35.6 (34.2–37.2) 34.8 (34.0–35.6) 0.003
Education level (n = 504)
Higher education degree or more 94.4 (87.2–97.7) 97.5 (90.4–99.4) 92.7 (85.5–96.5) 99.0 (92.9–99.9) 99.0 (93.2–99.9) 97.7 (95.8–98.7) 0.122
Time in the position (n = 505) 
Average in months 26.3 (20.1–32.5) 43.0 (32.2–53.7) 31.4 (24.3–38.5) 54.2 (41.8–66.6) 49.5 (40.4–58.6) 40.9 (36.7–45.1) < 0.001
Academic background (n = 505) 
Pharmacist 87.5 (78.8–93.0) 84.7 (75.0–91.1) 88.1 (80.0–93.2) 94.8 (88.0–97.8) 95.0 (88.6–97.9) 90.7 (87.3–93.4) < 0.001
Professionals responsible for the dispensing of medicines
Sex (n = 1,139) 
Female 77.5 (70.6–83.2) 80.9 (72.2–87.3) 68.8 (51.6–82.0) 69.7 (52.8–82.6) 87.4 (81.1–91.9) 77.4 (71.2–82.6) 0.087
Age (n = 1,137) 
Average in years 37.9 (36.5–39.3) 37.2 (34.8–39.6) 36.3 (33.6–39.0) 36.7 (36.2–41.2) 37.6 (34.9–40.3) 37.5 (36.5–38.6) 0.785
Education level (n = 1,139)
Up to high school 68.3 (58.3–76.9) 72.7 (61.1–81.8) 27.0 (17.3–39.5) 28.3 (15.6–45.7) 42.2 (26.7–59.3) 50.3 (43.0–57.7) < 0.001
Time in the position (n = 1,139)* 
Average in years 3.8 (3.4–4.3) 3.2 (2.5–3.9) 4.9 (3.4–6.3) 4.5 (3.6–5.4) 6.1 (4.4–7.9) 4.5 (4.0–5.0) 0.102
Academic background (n = 1,139) 
Pharmacist 8.9 (6.0–13.1) 2.6 (0.5–11.2) 32.7 (20.0–48.5) 33.4 (22.0–47.1) 13.8 (6.5–26.9) 16.6 (12.4–21.7) < 0.001
Physicians
Sex (n = 1,585)
Male 53.0 (46.8–59.2) 57.4 (50.1–64.3) 54.2 (46.7–61.4) 57.6 (51.4–63.6) 51.5 (45.2–57.8) 55.8 (52.2–59.2) 0.509
Age (n = 1,531) 
Average in years 42.1 (40.6–43.6) 41.7 (39.5–43.9) 39.0 (37.0–41.0) 41.0 (39.4–42.6) 42.6 (40.8–44.4) 41.3 (40.5–42.1) 0.033
Time since graduation (n = 1,578)
Average in years 13.8 (12.5–15.2) 13.2 (11.3–15.0) 11.2 (9.6–12.8) 14.6 (12.8–16.3) 14.9 (13.4–16.4) 13.5 (12.8–14.3) 0.005
Time in the position* (n = 1,585)
Average in months 27.9 (21.2–34.6) 31.8 (25.6–38.1) 37.8 (30.2–43.3) 48.5 (39.1–47.8) 51.5 (42.2–60.8) 39.3 (35.8–42.8) < 0.001
Education level
At least one residency 93.8 (89.9–96.2) 86.3 (80.4–90.6) 89.5 (83.8–93.3) 92.2 (88.2–95.0) 94.3 (90.5–96.6) 90.5 (88.0–92.5) 0.009
* Average time in the position on the health unit where the interview was carried out. DNA: does not apply
Source: PNAUM – Services, 2015.
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(sometimes 31.0%, rarely 24.1%, and never 31.1%), although the majority of coordinators 
assumed that the LME only partially (70.1%; 95%CI 64.6–75.0) meets the health demands of 
the city. Few coordinators reported the existence of therapeutic form or clinical protocols 
(22.9% and 26.4%, respectively). None of the results presented for these actors showed 
statistically significant differences between the regions of the Country.
According to the perception of the professionals responsible for the dispensing of medicines, 
most recognized the existence of a LME in the city (89.1%; 95%CI 83.8–92.8) and stated that 
the LME is present in the UBS for consultation by the health team (91.3%; 95%CI 86.5–94.5), 
especially in the Southeast region (96.5%) (Table 3).
Table 2. Characteristics of the medicine selection process, according to the perception of coordinators of pharmaceutical services, by region 
in Brazil. National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Indicator of the selection of medicines
North Northeast Midwest Southeast South Brazil
p 
% (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI)
Existence of a formally constituted PTC 
(n = 503)
10.7 (6.0–18.3) 9.5 (4.8–18.0) 13.6 (8.2–21.9) 13.3 (7.8–21.7) 15.6 (9.8–23.9) 12.5 (9.5–16.3) 0.628
Existence of standard operating 
procedures (n = 491)
45.9 (35.6–56.6) 48.8 (37.7–60.0) 51.5 (41.4–61.4) 56.5 (46.5–66.1) 45.9 (36.4–55.7) 50.6 (45.3–55.8) 0.564
Existence of LME (n = 495) 70.6 (60.3–79.1) 90.8 (81.8–95.6) 82.9 (73.7–89.2) 86.9 (78.3–92.4) 82.0 (73.2–88.4) 85.3 (81.4–88.5) 0.077
Periodic update of the LME (n = 419) 82.9 (71.8–90.3) 83.8 (73.3–90.7) 83.1 (73.5–89.7) 81.2 (71.1–88.3) 73.1 (62.6–81.5) 80.4 (75.6–84.5) 0.347
Participation of the respondent in the 
development of the LME (n = 418)
90.5 (80.3–95.7) 87.0 (76.9–93.1) 84.7 (74.8–91.1) 90.1 (81.3–95.0) 88.0 (79.0–93.4) 88.2 (84.0–91.4) 0.592
Professionals request changes on the LME (n = 438) 0.804
Sometimes 33.8 (23.8–45.4) 30.2 (20.8–41.6) 31.3 (22.2–42.1) 29.2 (20.5–39.8) 33.6 (24.3–44.3) 31.0 (26.1–36.4)
Rarely 23.5 (16.6–36.7) 25.8 (17.0–36.9) 25.8 (17.0–36.9) 24.1 (16.1–34.4) 23.1 (15.4–33.3) 24.1 (19.6–29.3)
Never 33.5 (23.5–45.1) 31.4 (21.9–42.8) 31.4 (21.9–42.8) 35.9 (26.3–46.7) 23.8 (15.8–34.1) 31.1 (26.2–36.5)
LME meets the health demands of the city (n = 426) 0.349
Completely 24.6 (15.6–36.5) 27.2 (18.1–38.7) 29.3 (20.4–40.1) 34.6 (25.1–45.5) 27.8 (19.2–38.2) 29.7 (24.7–35.1)
Partially 75.4 (63.5–84.4) 72.8 (61.3–81.9) 70.7 (59.9–79.6) 65.4 (54.5–74.9) 71.1 (60.5–79.7) 70.1 (64.6–75.0)
Provision of non-standard medicines  
(n = 506)
48.5 (38.3–58.7) 38.4 (28.4–49.6) 31.2 (22.7–41.0) 39.0 (29.8–49.2) 48.7 (39.1–58.4) 41.1 (36.2–46.3) 0.222
Existence of criteria for provision of 
non-selected medicines (n = 425)
64.8 (52.7–75.2) 56.1 (44.4–67.1) 72.8 (61.9–81.6) 73.9 (63.3–82.3) 71.1 (60.5–79.7) 67.0 (61.5–72.1) 0.081
Existence of a therapeutic form (n = 495) 21.0 (13.7–30.7) 27.9 (19.0–39.1) 16.2 (10.0–25.1) 23.8 (16.2–33.4) 18.3 (11.9–27.2) 22.9 (18.7–27.7) 0.252
Existence of clinical protocols (n = 487) 22.9 (15.3–32.9) 23.4 (15.2–34.3) 31.8 (23.3–41.8) 32.5 (23.7–42.8) 21.2 (14.2–30.4) 26.4 (22.0–31.3) 0.221
PTC: Pharmacy and Therapeutics Committee; LME: List of Essential Medicines of the cities and of the Federal District. 
Source: PNAUM – Services, 2015.
Table 3. Characteristics of the medicine selection process, according to the perception of professionals responsible for the dispensing of medicines 
in the basic health unit, by region in Brazil. National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Indicator of the selection of 
medicines
North Northeast Midwest Southeast South Brazil
p
% (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI)
Existence of LME (n = 1,139) 84.6 (76.3–90.4) 88.7 (78.3–94.5) 92.0 (85.1–95.8) 86.6 (72.9–94.0) 95.7 (90.9–98.0) 89.1 (83.8–92.8) 0.189
The LME is available in the 
health units for consultation of 
professionals (n = 1,041)
80.2 (72.6–86.2) 88.6 (75.5–95.1) 90.1 (81.4–95.0) 96.5 (91.7–98.6) 93.1 (84.4–97.1) 91.3 (86.5–94.5) 0.057
The respondent knows the 
procedures for inclusion or 
exclusion of medicines in the LME 
(n = 930)
28.0 (21.3–35.9) 36.9 (27.9–46.9) 49.9 (34.1–65.7) 66.8 (50.9–79.7) 42.2 (27.8–58.1) 47.8 (40.6–55.2) < 0.001
The respondent has already made 
a claim for inclusion/exclusion of 
medicines in the LME (n = 930)
31.0 (23.1–40.3) 42.1 (30.1–55.2) 66.2 (50.2–79.2) 45.7 (28.5–63.9) 44.9 (29.4–61.6) 44.4 (36.3–52.9) 0.528
The LME meets the health demands 
of the city (n = 930)
57.7 (49.1–65.9) 67.0 (55.1–77.0) 78.7 (64.1–88.4) 73.9 (55.1–86.7) 75.5 (60.5–86.1) 70.9 (63.4–77.3) 0.413
LME: List of Essential Medicines of the cities.
Source: PNAUM – Services, 2015.
6s
Selection of medicines in Brazil Karnikowski MGO et al.
https://doi.org/10.11606/S1518-8787.2017051007065
The percentage of these professionals who knew the procedures for changing the LME was 
47.8% (95%CI 40.6–55.2), with statistically significant difference between the regions (p < 0.001). 
According to Table 3, this proportion was lower in the North (28.0%; 95%CI 21.3–35.9) and 
higher in the Southeast (66.8%; 95%CI 50.9–79.7). The percentage of respondents who declared 
having already claimed for changes was 44.4% (95%CI 36.3–52.9), higher than the percentage of 
coordinators of pharmaceutical services. From the perspective of most of these professionals 
(70.9%; 95%CI 63.4–77.3), the LME meets the health demands of the city.
Physicians were asked about the characteristics of the selection of medicines, considering 
that they are the prescribers (Table 4). Only 27.2% (95%CI 23.7–30.9) of physicians reported 
to have knowledge of the procedures to change the LME, but 76.5% (95%CI 69.2–82.5) would 
have some claim to change it. Most reported to base their claims in clinical experiences 
(80.0%; 95%CI 71.7–86.4) or scientific articles (54.8%; 95%CI 45.5–63.7). 
Most physicians declared to know of the existence of the LME (95.3%; 95%CI 93.5–96.6), 
without significant differences between the regions of the Country (p = 0.092) (Table 4), 
with lower proportions in the North and Midwest regions (90.9% and 92.8%, respectively) 
Table 4.Characteristics of the medicine selection process, according to the perception of physicians, by region in Brazil. National Survey 
on Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Indicator of the selection of medicines
North Northeast Midwest Southeast South Brazil
p
% (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI)
Knowledge of the respondent regarding the 
procedures for inclusion or exclusion of 
medicines in the LME (n = 1.254)
25.8 (19.6–33.2) 27.7 (20.8–35.7) 21.2 (23.8–36.6) 29.8 (23.8–36.6) 24.2 (18.8–30.6) 27.2 (23.7–30.9) 0.542
Existence of a claim for inclusion/exclusion 
of medicines in the LME (n = 282)
80.4 (64.3–90.3) 80.3 (77.9–92.1) 89.5 (75.8–95.9) 67.9 (54.0–79.2) 75.6 (62.3–85.3) 76.5 (69.2–82.5) 0.167
Base for solicitationa
Scientific article (n = 204) 40.4 (25.1–57.7) 44.0 (27.9–61.5) 52.9 (33.3–71.6) 66.9 (50.0–80.4) 63.2 (46.2–77.5) 54.8 (45.5–63.7) 0.095
Scientific events (n = 203) 34.4 (20.3–51.9) 16.2 (7.1–32.8) 35.6 (19.3–55.9) 35.8 (21.6–53.1) 40.8 (25.5–58.1) 29.0 (21.6–37.7) 0.060
Journals (n = 203) 17.9 (8.3–34.6) 14.4 (5.8–31.6) 36.5 (20.1–56.7) 33.2 (20.3–49.4) 22.8 (12.0–39.0) 23.1 (16.6–31.2) 0.145
Media (television, magazines, radio, 
internet etc.) (n = 202)
11.8 (4.3–28.5) 6.8 (1.7–23.6) 6.0 (1.5–20.7) 8.4 (2.5–24.6) 6.9 (2.1–20.3) 7.6 (3.9–14.4) 0.933
Visit of representative/propagandist  
(n = 201)
11.8 (4.3–28.5) 14.0 (5.5–31.4) 10.9 (3.4–29.5) 9.2 (3.2–23.7) 25.7 (13.2–44.0) 14.4 (9.0–22.1) 0.261
Clinical experience (n = 200) 85.4 (70.1–93.6) 82.2 (64.5–92.1) 83.2 (62.6–93.6) 80.7 (64.2–90.6) 71.3 (54.3–83.8) 80.0 (71.7–86.4) 0.546
Existence of LME (n = 1,451) 90.9 (86.1–94.2) 94.8 (90.5–97.3) 92.8 (87.4–96.0) 95.5 (92.0–97.5) 98.1 (95.1–99.3) 95.3 (93.5–96.6) 0.092
Participation in the development of the 
LME (n = 1,311)
10.9 (7.1–16.5) 13.7 (8.9–20.4) 12.8 (8.6–18.7) 17.4 (12.5–23.8) 16.1 (11.8–21.5) 15.1 (12.5–18.3) 0.523
The LME meets completely the health 
demands of the city (n = 1,296)
14.2 (9.7–20.2) 12.5 (7.9–19.1) 10.0 (5.9–16.6) 15.2 (10.7–21.2) 10.7 (7.5–15.1) 13.0 (10.5–15.9) 0.223
Knowledge of the existence of the LME  
(n = 1,381) 
93.9 (89.7–96.4) 95.3 (90.7–97.6) 95.3 (90.7–97.7) 95.9 (92.4–97.8) 97.7 (94.5–99.1) 95.9 (94.1–97.1) 0.502
Form of access to the LME: b
Available in the medical office (n = 1,303) 72.1 (64.9–78.3) 74.6 (67.3–80.8) 74.3 (66.8–80.6) 81.3 (75.6–85.9) 79.6 (73.8–84.4) 77.6 (74.3–80,6) 0.181
Available on the internet (n = 1,172) 17.7 (12.6–24.3) 11.0 (6.8–17.2) 21.3 (14.9–29.4) 24.7 (19.3–31.0) 22.8 (17.4–29.3) 18.6 (15.9–21.7) 0.001
Available at the pharmacy (n = 1,259) 66.8 (59.4–73.4) 63.3 (55.0–70.9) 74.0 (65.8–0.7) 66.3 (59.0–73.0) 62.9 (56.0–69.4) 65.0 (61.0–68.8) 0.551
Available by the SMS or SES-DF (n = 1,149) 49.2 (41.7–56.7) 51.5 (42.9–60.0) 51.4 (42.5–60.3) 49.8 (41.9–57.7) 53.6 (46.7–60.5) 51.3 (47.1–55.0) 0.898
Availability of TF, Consensus, Guidelines, or 
Lines of Care in the medical office
51.6 (45.0–58.2) 46.7 (39.3–54.3) 41.8 (34.6–49.3) 54.7 (48.0–61.3) 50.1 (43.6–56.6) 49.9 (46.3–53.6) 0.191
The patient requests a change of medicine: 
Always, repeatedly, or sometimes (n = 1,578) 56.8 (50.3–63.0) 63.3 (55.9–70.0) 67.5 (60.7–73.8) 71.4 (65.3–76.8) 68.2 (61.5–74.2) 66.5 (63.0–69.8) 0.065
LME: List of Essential Medicines of the cities; SMS: Municipal Secretariat of Health; SES-DF: State Secretariat of Health of the Federal District; 
TF: Therapeutic Form. 
a Type of material consulted to make the request for inclusion in the standardized List of Medicines: scientific article, events, journals, media (magazines, 
television, radio, and internet); visit of representative/propagandist, clinical experience. 
b Options of access to the standardized List of Medicines mentioned by physicians: in the medical office, on the internet, at the pharmacy, at the Municipal 
Secretariat of Health.
Source: PNAUM – Services, 2015.
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and higher in the South region (98.1%). The form of access to the lists varied significantly: 
availability in the medical office (77.6%; 95%CI 74.3–80.6); in the UBS pharmacy (65.0%; 
95%CI 61.0–68.8); or in the secretariat of health (51.3%; 95%CI 47.1–55.0); and lower internet 
access (18.6%; 95%CI 15.9–21.7). 
The availability of therapeutic form or consensus, clinical practice guidelines or lines 
of care in the medical offices of the UBS was mentioned by half of physicians (49.9%; 
95%CI 43.6–53.6) (Table 4).
An interesting fact was that the physicians declared that many patients request a change 
of medicines always, repeatedly, or sometimes (66.5%; 95%CI 63.0–69.8). Few physicians 
considered that the LME meets the health demands of the city (13.0%; 95%CI 10.5–15.9). 
Unlike the coordinators of pharmaceutical services, few physicians of the UBS declared to 
participate in the development of the LME (15.1%; 95%CI 12.5–18.3).
DISCUSSION 
The data collected by PNAUM – Services are unseen to the Country regarding the 
characteristics of the medicine selection process in Brazilian cities and in the Federal District. 
PNAUM is a pioneer descriptive research with regional and national representativity and 
approach based on the perspectives of different professionals.
We noticed that the average age of all the interviewed professionals was 38 years, higher 
for physicians (as expected due to the time of undergraduate courses and residency of the 
professional) and lower for coordinators of pharmaceutical services. This reflects that the 
sample represents adults in a phase of professional improvement and increase of maturity. 
Working time in the position was low and quite similar between physicians and coordinators of 
pharmaceutical services, which could represent a certain similarity with the political-electoral 
cycle experienced by the Brazilian cities. The low average age of professionals responsible 
for dispensation could be related to other factors, such as the education level required for 
this occupation. 
The low education level among the professionals responsible for the dispensing of medicines 
(50.3% up to high school) is a point that deserves reflection, as it may represent a professional 
who is not adequately prepared to provide guidance on the correct use of medicines. 
This shows the weakness that the patient of SUS primary health care has to achieve safe 
and responsible use of medicines, as referred to in PNM7 (in its guidelines, priorities and 
responsibilities of each federated entity) and in the strategic axis XIII of the Política Nacional 
de Assistência Farmacêutica (PNAF – National Policy of Pharmaceutical Services)8. 
The selection process for medicines in the context of the logistics cycle of pharmaceutical 
services is a fundamental and little studied stage that can influence the promotion of a safer, 
more effective, and less costly use of medicines4,10. 
We highlight that the PNM7 establishes that the management of pharmaceutical services 
must be decentralized, with the selection, programming, and procurement of medicines made 
based on epidemiological criteria to better meet local needs for medicines. For the Brazilian 
cities and Federal District, therefore, the effective and perennial selection of medicines is an 
important factor in the management of financial resources and in the access to essential 
medicines for the patients of health services. 
Despite this premise, Brazilian states, cities, and Federal District have experienced difficulties 
in conducting the selection process, considering the relatively recent context of full 
decentralization of pharmaceutical services3. Therefore, the structuring of a multidisciplinary 
PTC, including health professionals at various levels of health care and management, is scarce 
in the Country2,4. 
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The results of this research show two concerning aspects regarding compliance to 
pharmaceutical policiesa,b. Only 12.5% of respondents described the existence of a formally 
constituted PTC, and only 27.2% of physicians reported to know the criteria for changing 
the LME, such as inclusion or exclusion of medicines.
However, the existence of a LME is quite recognized by the interviewed professionals 
(85.3% among those in charge of pharmaceutical services, 89.1% among those responsible 
for  the dispensing of medicines, and 95.3% among physicians), which denotes that 
there is no technical process free from conflict of interest in the selection of medicines. 
If there is no constituted PTC, how is the process of selection of medicines conducted? 
The non-existence of a formalized PTC opens space for the insertion of medicines in the 
LME to be made without criteria of quality, safety, and effectiveness, as established by the 
World Health Organization2,12. 
The ability of the LME to meet local needs for medicines can be considered quite low in the 
perspective of 13% of primary health care physicians, 29.7% of coordinators of pharmaceutical 
services, and 70.9% of professionals responsible for the dispensing of medicines. 
This discrepancy in the results can show different views between these professionals. 
Physicians may be more susceptible to the propagandists of pharmaceutical companies 
to prescribe medicines that are not listed in the LME, as this advertising is not always 
accompanied by the criteria of essentiality that must guide the selection of medicines11. 
At the same time, these prescribers can adapt their prescription to the availability 
of medicines at the UBS, which can thus influence the perception of professionals 
responsible for  the dispensing of medicines on the UBS. In addition, when prescribing a 
medicine that is not listed in the LME, the physician should guide patients to purchase 
the medicines and, therefore, this demand would not be perceived by those dispensing 
the medicines. Anyway, the results found for physicians and professionals who in charge 
of the dispensing of medicines in the UBS are antagonistic and deserve to be investigated 
with more depth. 
Still concerning the prescribers, among those who knew the procedures for changing the 
LME, 76.5% had already claimed for the inclusion or exclusion of medicines, which may be 
natural, as they are actors who are closely related to the therapeutic choice. However, little 
more than half of them (54.8%) reported doing this request based on scientific articles. 
Considering that the selection of medicines should be based on the best evidence, this can 
be considered worrisome2,4. 
The small availability of therapeutic forms and consensus, guidelines and/or clinical protocols 
also stands out – estimated, respectively, at 22.9% and 26.4%, from the perspective of the 
coordinators of pharmaceutical services, and at 49.9% in the perspective of primary health 
care physicians. According to Wannmacher11, a LME must be complemented by a therapeutic 
form and clinical protocols, to influence the rational selection and guidance for the use 
of medicines adopted in the prevention and treatment of diseases that are prevalent and 
relevant to the Country.
The cross-sectional design is a limitation of the study, which, although being able to show 
the reality of the medicine selection process in the Country, is not specific regarding 
the evolution of this process. Another limitation refers to the significant percentages of 
non-response to some variables in the sample. However, the originality of the research, along 
with the size and scope of the sampling, allow us to meet the perspectives of different health 
professionals and provide evidence that can be used for the improvement of the actions from 
the guidelines and strategic goals of PNM7 and PNAF8, respectively. Improving the process 
of selection of medicines in the cities, allocating apt professionals to the dispensing of 
medicines, and facilitating the access by primary health care professionals to the guidelines 
and evidence-based clinical protocols will provide a better use of public resources and the 
safe and responsible use of medicines in SUS. 
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